Skip to search.
 TSX Up 0.11% TSX Ventures Down 0.09%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
5.40 Up 0.26(5.06%) Dec 9, 4:00PM EST
Prev Close:5.14
Open:5.14
Bid:4.50 x 2000
Ask:6.87 x 200
1y Target Est:4.00
Beta:1.02139
Next Earnings Date:N/A
Day's Range:4.97 - 5.44
52wk Range:3.55 - 10.98
Volume:191,948
Avg Vol (3m):145,583
Market Cap:186.05M
P/E (ttm):128.57
EPS (ttm):0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OSIRUp 5.06%186.05M
UCBJY 0.00%5.81B
BIIBDown 0.61%62.61B
ABTUp 1.34%57.71B

Key Statistics

Forward P/E (1 yr):77.14
P/S (ttm):2.04
Ex-Dividend Date:14-Oct-15

Analysts

Annual EPS Est (Dec-15) :0.14
Quarterly EPS Est (Dec-15) :0.12
Mean Recommendation*:5.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback